The LIM Protein Ajuba Restricts the Second Heart Field Progenitor Pool by Regulating Isl1 Activity  by Witzel, Hagen R. et al.
Developmental Cell
ArticleThe LIM Protein Ajuba Restricts
the Second Heart Field Progenitor Pool
by Regulating Isl1 Activity
Hagen R. Witzel,1 Benno Jungblut,2 Chong Pyo Choe,3 J. Gage Crump,3 Thomas Braun,2 and Gergana Dobreva1,*
1Origin of Cardiac Cell Lineages Group, Max Planck Institute for Heart and Lung Research, Parkstr. 1, 61231 Bad Nauheim, Germany
2Max Planck Institute for Heart and Lung Research, Ludwigstr. 43, 61231 Bad Nauheim, Germany
3Broad California Institute for Regenerative Medicine Center, University of Southern California Keck School of Medicine,
1425 San Pablo Street, BCC 406, Los Angeles, CA 90089, USA
*Correspondence: gergana.dobreva@mpi-bn.mpg.de
http://dx.doi.org/10.1016/j.devcel.2012.06.005SUMMARY
Morphogenesis of the heart requires tight control
of cardiac progenitor cell specification, expansion,
and differentiation. Retinoic acid (RA) signaling
restricts expansion of the second heart field (SHF),
serving as an important morphogen in heart develop-
ment. Here, we identify the LIM domain protein Ajuba
as a crucial regulator of the SHF progenitor cell
specification and expansion. Ajuba-deficient zebra-
fish embryos show an increased pool of Isl1+ cardiac
progenitors and, subsequently, dramatically in-
creased numbers of cardiomyocytes at the arterial
and venous poles. Furthermore, we show that Ajuba
binds Isl1, represses its transcriptional activity, and
is also required for autorepression of Isl1 expression
in an RA-dependent manner. Lack of Ajuba abro-
gates the RA-dependent restriction of Isl1+ cardiac
cells. We conclude that Ajuba plays a central role in
regulating the SHF during heart development by
linking RA signaling to the function of Isl1, a key tran-
scription factor in cardiac progenitor cells.
INTRODUCTION
Heart formation is a complex morphogenetic process involving
specification, differentiation, and migration of cardiac progenitor
cells. Defects in this program are responsible for the high rate of
congenital cardiac abnormalities in humans underscoring the
importance of understanding the molecular mechanisms regu-
lating cardiogenesis (Bruneau, 2008; Srivastava, 2006a). Using
different model systems, including Drosophila, Xenopus, zebra-
fish, chick, and mouse, substantial progress has been made to
unveil the principal mechanisms and the key molecular players
driving heart development. It has been demonstrated that the
heart is generated by two distinct progenitor cell populations,
referred to as first and second heart fields (FHFs and SHFs,
respectively), which have different regional contribution to the
developing heart (Buckingham et al., 2005; Cai et al., 2003; Kelly
et al., 2001; Olson, 2006; Waldo et al., 2001). The FHF and SHF
progenitor cells are distinguished by expression of specific58 Developmental Cell 23, 58–70, July 17, 2012 ª2012 Elsevier Inc.transcription factors, as well as signaling molecules, which
have to act together in a coordinated manner for the proper
development of the heart (Black, 2007; Buckingham et al.,
2005; Evans et al., 2010; Laugwitz et al., 2008; Srivastava,
2006b; Vincent and Buckingham, 2010).
Islet1 (Isl1), a LIM homeodomain transcription factor, has
been regarded as a marker of the SHF (Cai et al., 2003; Laugwitz
et al., 2005). Fate mapping experiments in mouse demonstrated
a contribution of Isl1+ cells to the venous and the arterial poles of
the heart (Cai et al., 2003). Ablation of Isl1 in mouse leads to
severely misshaped, unlooped hearts, lacking the right ventricle
and outflow tract (Cai et al., 2003). Similarly, Isl1 is necessary for
heart morphogenesis, cardiac marker gene expression, and
vasculogenesis of Xenopus embryos (Brade et al., 2007),
whereas in zebrafish Isl1 is required to complete the cardiomyo-
cyte differentiation process at the venous pole (de Pater et al.,
2009). Isl1 is transiently expressed in SHF progenitors before
migration into the heart tube and is downregulated during their
differentiation (Cai et al., 2003; Laugwitz et al., 2008). Moreover,
Isl1 is required for the proliferation, survival, and migration of
these cells (Cai et al., 2003). Interestingly, it was also suggested
recently that Isl1 negatively regulates the number of cardiac
progenitor cells (Kwon et al., 2009). The mechanisms that coor-
dinate these opposing functions of Isl1 are currently unclear.
Another key regulator of the SHF is the transcription factor
Nkx2.5. Studies in different model organisms indicated that
Nkx2.5 and its homologs play important roles in cardiogenesis.
Drosophila tinman, for example, is involved in the specification
of the heart primordial cells (Azpiazu and Frasch, 1993; Bodmer,
1993), and mouse Nkx2.5 also plays a crucial role in heart
morphogenesis (Lyons et al., 1995). More recently, it was shown
that Nkx2.5 deficiency induces overspecification of cardiac
progenitors at early stages of heart development followed by
a failure to maintain proliferation of SHF progenitor cells and
subsequent truncation of the outflow tract (Prall et al., 2007). In
zebrafish, Nkx2.5 and Nkx2.7 are required to limit atrial cell
numbers and establish proper numbers of ventricular cardio-
myocytes (Targoff et al., 2008; Tu et al., 2009).
Heart development is also critically regulated by extracellular
signaling (Brand, 2003; Evans et al., 2010; Vincent and Bucking-
ham, 2010). Several studies have demonstrated a role of retinoic
acid (RA) signaling in the anteroposterior patterning of the
heart (Hochgreb et al., 2003; Ryckebusch et al., 2008; Sirbu
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Figure 1. Ajuba Interacts with Isl1
(A) FLAG-HA-tagged Ajuba and Isl1 were tran-
siently expressed in HEK293T cells. Proteins were
immunoprecipitated with an anti-HA antibody and
detected by immunoblot with an anti-Isl1 antibody.
IP, immunoprecipitation; WB, western blot.
(B) Isl1 and Myc-tagged LPP, Zyxin, LIMD1, and
WTIP were transiently expressed in HEK293T
cells, and immunoprecipitation with an anti-Isl1
antibody followed by immunoblot analysis with an
anti-myc antibody was performed.
(C) Coimmunoprecipitation of extracts from day 5
EBs differentiated from ES cells using anti-Isl1
antibody and detected with anti-Ajuba antibody.
(D) Schematic representation of wild-type Isl1 and
Isl1 deletion constructs (top). FLAG-HA-tagged
Ajuba and Isl1 or Isl1 deletion constructs were
transiently expressed in HEK293T cells, and
immunoprecipitation with an anti-Isl1 antibody
followed by immunoblot analysis with an anti-HA
antibody was performed (bottom).
(E) Schematic representation of wild-type Ajuba
and Ajuba deletion constructs (top). FLAG-HA-
tagged Ajuba or Ajuba deletion constructs and Isl1
were transiently expressed in HEK293T cells, and
immunoprecipitation with an anti-Isl1 antibody
followed by an immunoblot analysis with an anti-
HA antibody was performed. NES, nuclear export
sequence.
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Ajuba Restricts the Cardiac Progenitor Poolet al., 2008; Stainier and Fishman, 1992). Raldh2-deficient
mouse embryos, which lack RA signaling, exhibit posterior
expansion of Isl1 and Fgf8-positive populations, indicating that
RA is important to establish the posterior boundary of the SHF
(Ryckebusch et al., 2008; Sirbu et al., 2008). In the zebrafish
embryo, RA signaling restricts the cardiac progenitor pool
(Keegan et al., 2005;Waxman et al., 2008). Themechanisms link-
ing RA to the transcriptional regulators of heart development,
however, remain largely unclear.
Here, we identified Ajuba, a LIM domain protein, as a crucial
regulator of SHF progenitor cell specification and expansion.
Furthermore, we show that Ajuba binds Isl1 and represses its
transcriptional activity, which is required to downregulate the
expression of key transcription factors in the SHF such as
Mef2c, and to enable Isl1 to suppress its own expression. More-
over, we show that RA is a critical upstream regulator of this
process because it controls the number of Isl1+ cells in the heart
through an Ajuba-dependent mechanism. In addition, we find
that Ajuba regulates Nkx-2.5 levels, which might help to limit
cardiac specification.
RESULTS
Ajuba Interacts with Isl1 and Represses Its
Transcriptional Activity
To gain insight into the mechanisms underlying Isl1 function in
cardiac progenitor cell regulation, we performed a screen for
interaction partners of Isl1 (unpublished data). We identified
the LIM domain protein Ajuba as a prominent Isl1-binding
partner. Ajuba shuttles between the cytoplasm and the nucleus
and affects proliferation and cell fate decisions, processes that
are RA dependent (Kanungo et al., 2000). Thus, Ajuba potentiallyDprovides a link between RA signaling and Isl1, both of which can
negatively regulate progenitor cell numbers (Keegan et al., 2005;
Kwon et al., 2009).
To further investigate the interaction between Isl1 and Ajuba,
we transfected HEK293T cells with a FLAG-HA-tagged con-
struct of Ajuba alone or together with an Isl1 expression
plasmid. Coimmunoprecipitation with an anti-HA antibody and
subsequent immunoblot analysis with an anti-Isl1 antibody
indicated that Isl1 was efficiently coimmunoprecipitated (Fig-
ure 1A). To determine whether other members of the Ajuba/
Zyxin family interact with Isl1 and to address the specificity of
these interactions, we transfected Isl1 together with myc-
tagged Ajuba LIM proteins (LIMD1, WTIP) and the closely
related Zyxin LIM proteins (Zyxin, LPP) and performed coimmu-
noprecipitations. The Ajuba/Zyxin family is characterized by
three homologous C-terminal LIM domains and a unique
proline-rich N-terminal pre-LIM domain. We observed a strong
interaction of Isl1 with WTIP and a weaker one with LIMD1 (Fig-
ure 1B). In contrast, Zyxin and LPP did not bind Isl1 (Figure 1B),
indicating that Ajuba LIM proteins specifically interact with Isl1.
To confirm that Ajuba and Isl1 interact in cardiac progenitors
expressing endogenous levels of each protein, we performed
immunoprecipitation of Isl1 from nuclear extracts of embryoid
bodies (EBs) differentiated for 5 days, a stage enriched in
cardiac progenitors. We found that Ajuba was efficiently coim-
munoprecipitated together with Isl1 (Figure 1C). To delineate
the domains of Isl1 necessary for its interaction with Ajuba,
we transfected HEK293T cells with a FLAG-HA-Ajuba expres-
sion construct together with full-length Isl1 or Isl1 deletion
constructs (Figure 1D). We observed a strong interaction of
Ajuba with full-length Isl1 and truncated Isl1 protein lacking
LIM1, but not with mutants lacking the LIM2 domain (Figure 1D),evelopmental Cell 23, 58–70, July 17, 2012 ª2012 Elsevier Inc. 59
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Figure 2. Ajuba Colocalizes with Isl1 and
Represses Its Transcriptional Activity
(A) Subcellular localization of Isl1 and Ajuba in
HEK293T cells. FLAG-HA-tagged Ajuba and Isl1
full-length or deletion constructs were transiently
expressed and detected by immunofluorescence
using anti-HA or anti-Isl1 antibodies. Scale bars,
50 mm.
(B and C) HEK293T (B) and NIH 3T3 (C) cells were
transiently transfected with a 40 ng (B) or 50 ng (C)
luciferase reporter construct containing the Mef2c
cardiac-specific enhancer fragment (Dodou et al.,
2004) in front of a minimal fos promoter (Mef2c-
luc), alone or together with Isl1 (400 ng), Isl1
lacking the DNA-binding domain (Isl1DHOMEO,
400 ng), Ajuba (400 ng), or with constant amount of
Isl1 (400 ng), and increasing amounts of Ajuba
expression plasmid (100, 200, 300, 400 ng). The
luciferase levels were normalized for the b-galac-
tosidase activity of a cotransfected RSV-lacZ
reporter and presented as fold activation relative
to the luciferase levels of the Mef2c reporter
construct alone. Transfections were performed at
least three times in triplicates, and representative
experiments with the SDs are shown.
(D) ChIP of nuclear extracts from day 5 EBs, using
mouse or rabbit IgG (mIgG and rIgG, respectively)
as a control, anti-Isl1 and anti-Ajuba antibodies,
respectively. PCRs were performed using primers
flanking the two conserved Isl1-binding sites in the
Mef2c AHF enhancer.
(E) Confocal images of cryosections of E9 embryos
stained with anti-Ajuba (green) and anti-Isl1 (red)
antibodies. Scale bars, 100 mm.
See also Figure S1.
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Ajuba Restricts the Cardiac Progenitor Poolindicating that the LIM2 domain of Isl1 mediates the interaction
with Ajuba. An analogous approach was taken to identify the
domains in Ajuba required for interaction with Isl1, revealing
a strong association of Isl1 with full-length Ajuba and Ajuba
truncations lacking the LIM2 and LIM3 domains, but not the
LIM1 domain (Figure 1E). Thus, Isl1 specifically interacts with
the LIM1 domain of Ajuba.
We next wanted to determine whether Isl1 and Ajuba coloc-
alize in cells. Isl1 is a nuclear protein, and Ajuba was shown to
shuttle between the cytoplasm and the nucleus (Kanungo et al.,
2000). When expressed alone, Isl1 was localized in the nucleus,
whereas Ajuba was mainly detected in the cytoplasm (Fig-
ure 2A). Interestingly, when cells were transfected with Isl1
and Ajuba together (Figure 2A) or with Isl1 and Ajuba deletion
constructs that do not affect its binding to Isl1 (see Figure S1A
available online), a clear colocalization of Isl1 and Ajuba was
observed. Concomitant expression of both Isl1 and Ajuba60 Developmental Cell 23, 58–70, July 17, 2012 ª2012 Elsevier Inc.affected the localization of either protein:
Isl1 was partially retained in the cyto-
plasm, whereas significant amounts of
Ajuba protein localized to the nucleus
(Figures 2A and S1A). In contrast, no
colocalization was observed when Isl1
was expressed together with a truncated
Ajuba protein lacking the LIM1 domain orwhen Isl1 protein lacking the LIM2 domain was coexpressed
together with full-length Ajuba (Figure 2A). Furthermore,
a similar colocalization was evident when Isl1 was transfected
together with WTIP, which strongly interacted in the coimmuno-
precipitation experiments (Figure S1B). As expected, we did
not detect a significant colocalization of Isl1 with LIMD1, Zyxin,
or LPP (Figures S1B and S1C; data not shown), which
showed weak or no interaction with Isl1 in coimmunoprecipita-
tion experiments (Figure 1B). Moreover, the colocalization was
conserved between mouse and zebrafish (Figure S1D).
Next, we sought to determine the effect of Isl1-Ajuba interac-
tion on Isl1 transcriptional activity. We transfected HEK293T and
NIH 3T3 cells with Isl1 and Ajuba, together with a luciferase
reporter construct containing the Mef2c cardiac-specific
enhancer, which is directly bound and activated by Isl1 (Dodou
et al., 2004). Overexpression of Isl1, but not an Isl1 mutant
lacking the DNA-binding homeodomain, led to upregulation of
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Figure 3. Ajuba Knockdown in Zebrafish
Leads to an Increased Number of Cardio-
myocytes at the Arterial and Venous Poles
(A) Schematic representation of the Ajuba
genomic locus (left) and the exons coding the three
LIM domains (drawn to scale, right). The binding
sites of the AUG and the splice morpholino are
shown in red.
(B) Control or AUG MO-injected Tg(myl7:EGFP-
HsHRAS)s883 embryos at 48 hpf. Lateral views,
anterior to the left, are in the top-left and bottom
panels. Frontal views of the same embryos are in
the middle and right panels.
(C) Confocal images of control and Ajuba mor-
phant Tg(myl7:EGFP-HsHRAS)s883/Tg(5.1myl7:
nDsRed2)f2 hearts.
(D) Total number of atrial cells and number of
mGFP+DsRed+ and mGFP+DsRed cells in the
atrium at 48 hpf. Error bars represent SD (n = 5).
*p < 0.05; ***p < 0.001.
(E) Confocal images of control and Ajuba AUG
morphant ventricle at 48 hpf.
(F) Total number of ventricle cells. **p < 0.01.
See also Figure S2 and Table S1.
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Ajuba Restricts the Cardiac Progenitor Poolluciferase reporter expression. Importantly, cotransfection of
increasing amounts of Ajuba together with Isl1 led to a dose-
dependent downregulation of reporter gene expression indi-
cating that Ajuba suppresses Isl1 transcriptional activity (Figures
2B and 2C). To determine whether Ajuba binds Isl1 at regulatory
elements of Isl1 target genes, we performed chromatin immuno-
precipitation (ChIP) using control (IgG) or anti-Isl1 and anti-
Ajuba antibodies with extracts from day 5 EBs. Importantly,
both Isl1 and Ajuba were bound to the Mef2c anterior heart field
(AHF) enhancer, further corroborating our hypothesis that both
proteins form a complex to regulate Isl1 target gene expression
during cardiogenesis (Figure 2D). No binding was detected to
a control sequence in the b-globin locus (data not shown).
Next, we determined the expression and subcellular localization
pattern of Ajuba during embryonic development focusing on
the Isl1+ cardiogenic region. Interestingly, we found an accumu-
lation of Ajuba in the nucleus of Isl1+ cells (Figure 2E, boxedDevelopmental Cell 23, 5region 1), which was not seen in the
epithelium (Figure 2E, boxed region 2).
Ajuba Knockdown in Zebrafish
Leads to an Increased Number of
Cardiomyocytes at the Arterial
and Venous Poles
To investigate whether the transcriptional
suppression of Isl1 by Ajuba is crucial for
the restriction of SHF expansion and
differentiation, we turned to the zebrafish
system, where it was recently shown
that a conserved SHF is required for
cardiac development (Hami et al., 2011;
Lazic and Scott, 2011; Zhou et al.,
2011). We utilized the transgenic line
Tg(myl7:EGFP-HsHRAS)s883 that ex-
presses membrane-bound GFP (mGFP)under the control of the myl7 (cmlc2; cardiac myosin light-chain
2) promoter in all differentiated cardiomyocytes (D’Amico et al.,
2007). Two morpholinos (MOs) were designed to block either
translation (AUG MO) or splicing (Sp MO) of Ajuba mRNA
(Figure 3A) and tested for efficacy and specificity (Figure S2).
Importantly, the two nonoverlapping MOs produced the same
phenotype, confirming the specificity of the MO-mediated Ajuba
knockdown (Figures 3B and S2D). Ajuba morphants exhibited
developmental abnormalities including left-right axis malforma-
tions, enlarged hearts, and pericardial edema, whereas control
MO had no discernible effects (Figures 3B and S2D; Table
S1). The effects on left-right asymmetry of the heart were similar
to results reported for the Ajuba homolog in medaka fish
showing a situs inversus in 29% of Ajuba morphants (Nagai
et al., 2010; Table S1). Interestingly, 86.2% of the morphants
showed dramatically enlarged hearts (Figures 3B–3F; Table
S1). Furthermore, the relative positioning of the atria and the8–70, July 17, 2012 ª2012 Elsevier Inc. 61
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Ajuba Restricts the Cardiac Progenitor Poolventricles was altered in the Ajuba morphants (Figure 3C). In
addition, the beating frequency of Ajuba morphant hearts was
reduced (data not shown). Previous studies using transgenic
fish expressing both EGFP and dsRed in differentiating cardio-
myocytes under the control of the myl7 promoter revealed that
growth of the developing zebrafish heart is regulated by two
distinct phases of cardiomyocyte differentiation and that Isl1
seems required to complete cardiomyocyte differentiation at
the venous pole (de Pater et al., 2009). To investigate the poten-
tial role of Ajuba in this process, we injected Ajuba AUG MO
into a double transgenic line Tg(myl7:EGFP-HsHRAS)s883/
Tg(5.1myl7:nDsRed2)f2 (D’Amico et al., 2007; Mably et al.,
2003) (Figure 3C). Because EGFP becomes fluorescent very
soon after synthesis, but dsRed requires about 24 hr to mature,
this assay allowed us to determine the timing of cardiomyocyte
differentiation in response to Ajuba depletion. We observed
a significant increase of the total number of atrial cells (control,
105 ± 1, n = 5; Ajuba morphant, 161 ± 7, n = 5; p < 0.001; Figures
3C and 3D). Interestingly, this increase seems to be due to
a continuous generation of new cardiomyocytes because we
detected only slight differences in the number of mGFP+/
dsRed+ cells in Ajuba morphants but a dramatic increase of
the number of mGFP+/dsRed cells: 23 ± 3 in control hearts
and 75.5 ± 5 in Ajuba morphant hearts (Figures 3C and 3D).
This finding corresponds nicely to the decrease of mGFP+/
dsRed cells in Isl1 zebrafish mutants (de Pater et al., 2009),
arguing for a role of Ajuba in the regulation of Isl1. Furthermore,
we found a significantly enlarged arterial pole in Ajuba mor-
phants (Figure 3E). Moreover, the total number of ventricular
cardiomyocytes was significantly increased (control, 133 ± 6,
n = 3; Ajuba morphant, 208 ± 18, n = 3; p < 0.01; Figures 3E
and 3F).
Ajuba and Isl1 Restrict the Number of Isl1-Expressing
Cells in the Heart
To address whether the increased number of cardiomyocytes
at the arterial and venous poles is due to increased number of
Isl1-expressing cells in the heart, we performed Isl1 immunos-
taining of control and Ajuba morphant embryos at different
developmental stages. At the 24 somite stage, the number of
Isl1+ cells located in and at the periphery of the future atrium (Fig-
ure 4A) (de Pater et al., 2009) was already significantly increased.
Later during development, at 30 hr postfertilization (hpf), Isl1+
cells are found at both the arterial and venous poles (de Pater
et al., 2009; Hami et al., 2011). Importantly, we detected a sig-
nificant increase of Isl1+ cells at the periphery of both poles
and in the future atrium and ventricle (Figures 4B, S3A, and
S3B). At 48 hpf the number of Isl1+ cardiomyocytes, found at
the venous pole of the atrium, was also significantly higher (Fig-
ure S3C), and the number of Isl1-positive tiers was expanded
from three in control embryos to seven in the morphants (Fig-
ure 4C). To determine the effect of the additional Ajuba family
members on the number of Isl1-expressing cells in the heart,
we performed MO knockdown of LIMD1 and WTIP. Similar to
the Ajuba morphants, the WTIP-deficient embryos showed
a higher number of Isl1+ cells at the venous pole (Figure S3D).
In contrast, no change in Isl1 levels was detected in embryos
deficient for LIMD1 (Figure S3D). To further analyze whether
Ajuba restricts the number of Isl1-expressing cells, we overex-62 Developmental Cell 23, 58–70, July 17, 2012 ª2012 Elsevier Inc.pressed Ajuba by injecting mRNA into early-stage embryos.
Interestingly, increased concentrations of Ajuba resulted in
significantly smaller hearts and a complete absence of Isl1+ cells
at the venous pole of the heart (Figure 4D). To test whether the
increased number of Isl1+ cells in the heart can be due to
increased proliferation, we performed immunostaining with an
antibody recognizing Ser10-phosphorylated histone H3 (phos-
pho-H3). We could detect only very few (one to two) phospho-
H3-positive cells in the myocardium of the entire heart tube in
control embryos as reported previously (de Pater et al., 2009)
and in Ajuba-deficient embryos (data not shown), suggesting
that the increased number of Isl1+ cells is not due to increased
proliferation.
We next wanted to determine whether the observed pheno-
type in Ajuba-deficient embryos depends on its role in regulating
Isl1 activity. To this end, we performed MO knockdown of Isl1
(Hutchinson and Eisen, 2006) either alone or in combination
with Ajuba MO and performed anti-GFP (for myl7) and anti-Isl1
immunostaining. We did not detect any Isl1 staining at the
venous pole of the heart in the Isl1 and Isl1/Ajuba morphants,
confirming the efficacy of the MO-mediated Isl1 knockdown
(data not shown). Importantly, the double Isl1/Ajuba-deficient
zebrafish embryos did not show any increase in the total number
of cardiomyocytes in contrast to the Ajuba morphants (Figures
4E and S3E). Because injection of Isl1 MO prevents production
of Isl1 protein but does not affect transcription of the Isl1 gene,
we were also able to analyze activity of the Isl1 promoter in
absence of Isl1 protein. Surprisingly, absence of Isl1 protein or
both Isl1 and Ajuba caused a significantly higher and broadened
Isl1 expression similar to Ajuba-deficient embryos (Figure 4F),
suggesting that Isl1 restricts the number of Isl1-expressing cells.
Consistentwith this finding, overexpression of Isl1, but not a trun-
cated version lacking the LIM2 domain responsible for its inter-
action with Ajuba, led to an absence of Isl1+ cells at the venous
pole of the atrium (Figure S3F). Immunostaining for myl7-mGFP
combined with in situ hybridization for Isl1 revealed that the
expanded Isl1+ cell population in double Isl1/Ajuba-deficient
embryoswas located outside of the heart tube (Figure 4G), which
differs from the situation in control and Ajuba morphant embryos
where Isl1+ cells are localized at the venous pole inside the
atrium. Furthermore, we noticed mGFP+ cardiomyocytes in the
pericardial wall adjacent to the heart in Isl1/Ajuba morphants
(Figure 4E, arrows). Taken together, these data suggest that
Ajuba together with Isl1 plays an important role in restricting
the number of Isl1-expressing cells, but Isl1 is required for cardi-
omyocyte differentiation in the heart through Ajuba-independent
mechanisms.
Ajuba Restricts the Number of SHF Progenitor Cells
Because we detected an increase of Isl1+ cells in the heart at
24 somites and did not observe increased proliferation of Isl1+
cardiomyocytes in Ajuba morphants, we wanted to determine
whether Ajuba regulates cardiac progenitor cell numbers. To
explore this possibility, we first refined the expression pattern
of Isl1 and Ajuba during cardiogenesis by performing whole-
mount immunostaining and in situ hybridization at early develop-
mental stages, and comparing it to the Nkx2.5-expressing
domain using Nkx2.5:GFP transgenic embryos, which faithfully
recapitulated Nkx2.5 expression (Figures 5A, S4, and S5)
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Figure 4. Ajuba and Isl1 Restrict the Number of Isl1-Expressing Cells in the Heart
(A) Confocal images of control and Ajuba morphant Tg(myl7:EGFP-HsHRAS)s883 embryos stained with anti-GFP and anti-Isl1 antibodies at 24 somites.
(B and C) Confocal images of control and Ajuba morphant Tg(myl7:EGFP-HsHRAS)s883 embryos stained with anti-Isl1 antibodies (red) and visualized by GFP
fluorescence (green) for myl7 expression at 30 hpf (B) and at 48 hpf (C).
(D) Control and zAjuba mRNA-injected Tg(myl7:EGFP-HsHRAS)s883 embryos at 48 hpf, frontal view (top); in situ hybridization for Isl1 in control or zAjuba mRNA-
overexpressing embryos at 48 hpf (bottom).
(E) Confocal images of hearts of control, Ajuba, Isl1, and Ajuba/Isl1 morphant Tg(myl7:EGFP-HsHRAS)s883 embryos, stained with anti-GFP antibody. Arrows
show differentiated cardiomyocytes in the pericardial wall adjacent to the heart.
(F) In situ hybridization for Isl1 in control, Ajuba, Isl1, and Ajuba/Isl1-deficient embryos.
(G) Immunostaining with anti-GFP and in situ hybridization for Isl1 in control (left) and Ajuba/Isl1-deficient Tg(myl7:EGFP-HsHRAS)s883 (right) embryos from (F).
See also Figure S3.
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Ajuba Restricts the Cardiac Progenitor Pool(Chen and Fishman, 1996). At 5 somites Isl1-positive cells were
found in bilateral populations of cells lying within the anterior-
lateral plate mesoderm, a region known to contain heart precur-
sor cells (Figure S4), which is significantly earlier than apreviously
reported expression of Isl1 (Hami et al., 2011). Later, at 10 and 15
somites, Isl1 expression closely followed the established
patterns of zebrafish heart morphogenesis (Chen and Fishman,
1996), including convergence toward the midline (Figures 5A,
S4, and S5). At the 10 somite stage, Isl1 marked a progenitor
population that partially overlapped with the Nkx2.5 progenitor
population (Figure 5A). At 15 somites Isl1-expressing cells
were found in the anterior-lateral plate mesoderm; some Isl1+
cells were positioned at the inner margin of the cardiogenic
region, dorsal to the Nkx2.5-expressing cells, which start to invo-
lute at the innermargin (Figure S5C00 0, arrows). At 18 somites Isl1-Dexpressing cells were found at the future arterial and venous pole
(Figure S5D00 0, arrows). At 24 somites Isl1+ cells are positioned at
the base of the cardiac cone (Figures 4A and S5). In contrast,
Ajuba was broadly expressed in the developing embryo, and
covered the SHF, which is compatible with a role as a modulator
of Isl1 function (Figure S4). At 48 hpf the relatively broad expres-
sion domain of Ajuba became confined to the head region but
was not found in the heart (data not shown).
Next, we analyzed the Isl1 expression pattern in control
and Ajuba morphants using in situ hybridization (Figure 5B) at
3, 5, 10, and 15 somite stages. We detected a significant
expansion of Isl1+ cells in the cardiogenic regions of Ajuba-
deficient embryos at all developmental stages. Already at 3
somites, we could detect Isl1+ cardiac progenitors in the Ajuba
morphants, and at 5 somites the number was dramaticallyevelopmental Cell 23, 58–70, July 17, 2012 ª2012 Elsevier Inc. 63
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Figure 5. Ajuba Restricts the Number of SHF Progenitor Cells
(A) Confocal images of Nkx2.5:GFP transgenic embryos stained with anti-Isl1 and anti-GFP antibodies at the 10 somite stage. The top-middle panel shows
a higher magnification of the image in the top-left panel; the lines indicate the position of the transverse (xz) optical sections presented in top-right panel. NT,
neural tube; Tg, trigeminal placode.
(B) In situ hybridization of control and Ajuba morphant embryos at 3, 5, 10, and 15 somite stage with an Isl1 probe.
(C) In situ hybridization of control and Ajuba morphant embryos with probes for Mef2ca, Mef2cb, Tbx20, Tbx1, and Bmp4.
(D) Relative expression level of cardiac progenitor and cardiomyocyte marker mRNA normalized to GAPDH mRNA in day 5 EBs overexpressing either GFP only
(control) or both GFP and Ajuba. Error bars represent SDs derived from two independent pools of control and Ajuba-overexpressing ES cells subjected to
differentiation in EBs.
See also Figures S4, S5, and S6.
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Ajuba Restricts the Cardiac Progenitor Poolincreased compared to the control embryos (Figure 5B). In
contrast, we detected only few proliferating phospho-H3-posi-
tive Isl1-expressing cells in both control and Ajuba morphants
(Figure S6), suggesting that the increased number of Isl1+
cardiac progenitors is due to overspecification. Moreover, we
found a significant expansion of cells in Ajuba morphants that
express Mef2ca, Mef2cb, Tbx20, Tbx1, and Bmp4, which play
important roles in the SHF (Figure 5C), suggesting that Ajuba
restricts the SHF progenitor pool.
To examine whether the role of Ajuba in SHF progenitor cells
is evolutionarily conserved, we transfected mouse embryonic
stem (ES) cells with an expression plasmid carrying GFP alone
or together with Ajuba. GFP-expressing cells isolated by FACS
were subjected to differentiation in EBs to facilitate generation
of cardiac progenitor cells. RT-PCR revealed downregulation
of pan-cardiac genes and genes specifically expressed in the
SHF, whereas genes expressed in the FHF (Tbx5, Hand1)
showed no change (Figure 5D). Furthermore, the expression of
cardiomyocyte marker genes, such as Mlc2a and Mlc2v, was
downregulated (Figure 5D). Taken together, these data suggest64 Developmental Cell 23, 58–70, July 17, 2012 ª2012 Elsevier Inc.that Ajuba may have a conserved function in the negative regu-
lation of the number of SHF progenitor cells.
The Isl1-Ajuba Transcriptional Complex Negatively
Regulates Isl1 Expression in an RA-Dependent
Mechanism
RA signaling restricts the cardiac progenitor pool in zebrafish
(Keegan et al., 2005; Waxman et al., 2008) and induces Ajuba
expression and shuttling from the cytoplasm to the nucleus
(Kanungo et al., 2000). Furthermore, Isl1 serves as a negative
regulator of Isl1+ progenitor cells (Kwon et al., 2009), which is
in line with our findings that Isl1 restricts the number of Isl1+
cardiac cells at the venous pole (Figure 4F). Hence, we postu-
lated that Ajuba provides a link between RA signaling and Isl1.
To test this hypothesis, we treated day 3 EBs, differentiated
from ES cells, with RA and analyzed the expression of marker
genes of cardiac progenitor cells at day 5. Real-time PCR
analysis revealed a strong downregulation of Isl1 (Figure 6A,
left), whereas Tbx5 was upregulated by RA (Figure 6A, right),
consistent with previous reports (Liberatore et al., 2000).
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Figure 6. The Isl1-Ajuba Transcriptional
Complex Negatively Regulates Isl1 Expres-
sion in an RA-Dependent Mechanism
(A) Relative expression levels of cardiac progenitor
marker mRNA normalized to GAPDH mRNA in
day 5 EBs either nontreated or treated with 0.1 or
0.3 mM RA at day 3. Data are mean ± SD (n = 2).
*p < 0.05; **p < 0.01; ***p < 0.001.
(B) Western blot analysis of nuclear extracts from
day 5 EBs either nontreated or treated with 0.1 or
0.3 mM RA at day 3.
(C) ChIP of nuclear extracts from day 5 EBs either
nontreated or treated with 0.1 mM RA at day 3,
using anti-Isl1 and anti-Ajuba antibodies or IgG as
a control. PCRs were performed using primers
flanking a conserved Isl1 binding site in the Isl1
enhancer.
(D and E) P19 cells were transiently transfected
with 25 ng Isl1-luc reporter construct (Isl1-F; Kang
et al., 2009), alone or together with Isl1 (400 ng),
Ajuba (900 ng), or with constant amount of Isl1
(400 ng) and increasing amounts of Ajuba
expression plasmid (500 and 900 ng). P19 cell
were either nontreated (D) or treated with RA (E).
Data aremean ± SD (n = 4). **p < 0.01; ***p < 0.001.
(F) In situ hybridization for the atrial marker atrial
myosin heavy chain (Amhc; top panels) and Isl1
(bottom panels) at 48 hpf in control and zebrafish
embryos, treated with RA for 1 hr. WT, wild-type.
(G) In situ hybridization for Isl1 in control and Ajuba
morphant and RA-treated control or Ajuba mor-
phant zebrafish embryos at 48 hpf.
See also Figure S7 and Tables S2 and S3.
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Ajuba Restricts the Cardiac Progenitor PoolFurthermore, we monitored a strong upregulation of Ajuba
protein levels (Figure 6B). Based on our findings that Isl1 and
Ajuba form a complex and that Ajuba restricts the number of
Isl1+ cardiac progenitor cells, we analyzed whether the Isl1-
Ajuba complex might directly regulate Isl1 expression.
Sequence analysis of the Isl1 enhancer, which is sufficient to
direct expression of Isl1 in the SHF and its derivatives (Kang
et al., 2009), revealed the presence of a putative Isl1-binding
site (TTAATGG; Figure 6C). ChIP analysis of nuclear extracts
from day 5 EBs differentiated from ES cells demonstrated
specific binding of Isl1 and Ajuba to the conserved Isl1-binding
site. Interestingly, we detected stronger binding of Isl1 and Ajuba
upon RA treatment of EBs at day 3 (Figure 6C), supporting the
idea that RA signaling modulates Isl1 expression through regu-
lating the abundance of the Isl1-Ajuba complex on the Isl1 regu-
latory elements. To further test this hypothesis, we transfected
P19 embryonic carcinoma cells with plasmids encoding Isl1Developmental Cell 23, 5and Ajuba together with a luciferase
reporter construct containing the Isl1
enhancer and a minimal fos promoter
(Isl1-luc; Figure 6D). Importantly, expres-
sion of Isl1 or Ajuba alone did not
significantly affect Isl1 reporter gene
expression, but coexpression of both
proteins resulted in downregulation of
reporter gene levels. RA treatment of
P19 cells transfected with Isl1 alone wassufficient to repress Isl1 reporter gene activity (Figure 6E). This
effect was not dependent on exogenously introduced Ajuba,
presumably because the Ajuba gene was already strongly acti-
vated by RA in P19 cells (Figures 6B and 6E) (Kanungo et al.,
2000). To further determine whether the effects of RA on cardiac
cells aremediated via the Isl1-Ajuba complex, we treated control
and Ajuba morphant embryos with different concentrations of
RA at 50% epiboly. RA treatment led to shortening of the
atrium (Figure 6F; Table S2) and to a significant reduction of
the number of Isl1+ cells at the venous pole of the atrium at 48
hpf (Figure 6F; Table S2), which went along with a decrease of
Isl1 expression at the 10 somite stage (Figures S7A and S7B),
similar to RA treatment of mouse embryos (Ryckebusch et al.,
2008). Furthermore, treatment of embryos with DEAB, an inhib-
itor of the RA-producing enzyme retinaldehyde dehydrogenase,
led to expansion of Isl1 expression, confirming that RA plays
a role in restricting the number of Isl1+ cardiac cells (Figure S7C).8–70, July 17, 2012 ª2012 Elsevier Inc. 65
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Figure 7. Ajuba Regulates Nkx2.5 Levels
(A) In situ hybridization for Nkx2.5 in control and
Ajuba morphant embryos at 10 and 15 somites.
(B) Relative expression level of Nkx2.5 normalized
to Rpl13a in pools of control and Ajuba morphant
embryos at 10 and 15 somites. Error bars repre-
sent SDs derived from three independent pools of
control (n = 10) and Ajuba morphant embryos (n =
10). **p < 0.01.
(C) FLAG-HA-tagged Ajuba and Nkx2.5-myc
expression plasmids were transiently expressed in
HEK293T cells, and immunoprecipitation with an
anti-HA antibody followed by immunoblot analysis
with an anti-myc antibody was performed.
(D) Western blot analysis of lysates from day 5 EBs
overexpressing either GFP only or both GFP and
Ajuba using Nkx2.5 antibody. The two lanes were
spliced from the same exposure of the same blot.
(E) HEK293T cells were transfected with constant
amounts of Nkx2.5-myc (5 mg) and FLAG-H3.3
(1 mg, used as a control for transfection efficiency)
expression plasmids and increasing amounts of an
Ajuba plasmid (0.25, 0.5, 0.75 mg). Immunoblot
analysis of equal amounts of total protein extracts
was performed using either anti-myc, anti-HA or
anti-FLAG antibodies.
(F) Western blot analysis of whole-cell lysates from
HEK293T cells treated with either DMSO or MG-
132 using Nkx2.5 antibody. Ponceau staining
served as loading control.
(G) In situ hybridization of control and Nkx2.5/
Nkx2.7 morphant (Nkx-deficient) embryos at 3, 5,
10, and 15 somite stages and at 48 hpf with an Isl1
probe.
(H) Model for the control of the SHF progenitor
pool by Ajuba.
Developmental Cell
Ajuba Restricts the Cardiac Progenitor PoolImportantly, administration of RA to control and Ajuba morphant
embryos did not decrease the higher number of Isl1+ cells in
Ajuba morphants, whereas treatment of control embryos led to
a significant reduction of Isl1+ cells in the heart (Figure 6G; Table
S3). Taken together, our data suggest that the Isl1-Ajuba tran-
scriptional complex negatively regulates Isl1 expression in an
RA-dependent manner.
TheProtein Level of AjubaCorrelateswith that of Nkx2.5
To assesswhether additional factors besides Isl1may contribute
to the phenotype of Ajuba morphants, we analyzed the ex-
pression of Nkx2.5, which has also been shown to prevent over-
specification of cardiac progenitors (Prall et al., 2007). In situ
hybridization analysis of 10 and 15 somite embryos indicated
that the Nkx2.5 expression domain is reduced in Ajuba mor-
phants (Figure 7A). Real-time PCR analysis of pools of control
and Ajuba morphant embryos at 10 and 15 somites confirmed
lower Nkx2.5 mRNA levels in the morphants (Figure 7B).66 Developmental Cell 23, 58–70, July 17, 2012 ª2012 Elsevier Inc.Because Ajuba was found to interact
with another member of the Nkx2 class
of homeodomain-containing proteins,
Nkx2.1 (Missero et al., 2001), we wanted
to determine whether Ajuba also binds
Nkx2.5. Coimmunoprecipitation experi-
ments of HEK293T cells transfected withNkx2.5 and Ajuba expression constructs demonstrated that
Nkx2.5 indeed interacts with Ajuba (Figure 7C). Interestingly,
we consistently observed dramatically higher Nkx2.5 protein
levels in extracts (Figures 7C and 7D) and immunostaining
(data not shown) of cells overexpressing Ajuba, which suggested
that Ajuba may stabilize Nkx2.5, e.g., by protecting it from pro-
teasomal degradation. To assess this possibility, we transfected
HEK293T cells with Nkx2.5 alone or together with increasing
amounts of Ajuba and constant amounts of histone 3.3 (H3.3),
which served as a control for transfection efficiency (Figure 7E).
Western blot analysis revealed that increasing levels of Ajuba led
to a significant increase of Nkx2.5 protein levels (Figure 7E).
Furthermore, treatment of HEK293T cells, which express low
levels of endogenous Nkx2.5, with the proteasomal inhibitor
MG-132 resulted in an increase of Nkx2.5 protein levels, indi-
cating that Nkx2.5 is targeted for proteasomal degradation (Fig-
ure 7F). Interestingly, Nkx-deficient embryos that lack both
Nkx2.5 and Nkx2.7 show enlarged atria (Targoff et al., 2008;
Developmental Cell
Ajuba Restricts the Cardiac Progenitor PoolTu et al., 2009) similar to Ajubamorphants. To determinewhether
the enlarged size of the atrium inNkx-deficient embryosmight be
caused by an increase of Isl1+ cardiac progenitors, we per-
formed in situ hybridization for Isl1 using control and Nkx-defi-
cient embryos at 3, 5, 10, and 15 somites and 48 hpf. We
detected a dramatic expansion of Isl1+ cardiac progenitor cells
as early as at the 3 somite stage, suggesting that Nkx2.5
regulates Isl1 progenitor specification in a similar manner as
Ajuba (Figure 7G). Later, at 48 hpf, a large portion of the atrium
consisted of Isl1+ cardiomyocytes (Figure 7G). Taken together,
these findings suggest that downregulation of Nkx2 proteins
may contribute to the Ajuba morphant phenotype.
DISCUSSION
The control of cardiac progenitor cell specification, expansion,
and differentiation is essential for cardiac development and
requires the coordinated function of different transcription
factors and signaling pathways. The transcription factors Isl1
and Nkx2.5 as well as RA signaling play important roles in the
regulation of the cardiac progenitor pool, but the precise mech-
anisms controlling their activity remain unclear. We reasoned
that identification of molecules that control the activity of Isl1
might be a means to uncover the mechanisms that determine
cardiac progenitor cell numbers and mediate RA-dependent
restriction of SHF expansion. Our experiments identified Ajuba,
a member of the Ajuba/Zyxin protein family, as an Isl1-binding
partner. Ajuba is important for the formation and the mainte-
nance of cell-cell junctions (Marie et al., 2003) and plays a role
in cell migration (Kisseleva et al., 2005; Pratt et al., 2005). Ajuba
shuttles into the nucleus and affects proliferation and cell fate
decisions, a process that is RA dependent (Kanungo et al.,
2000). Moreover, Ajuba acts as a corepressor of Snail/Slug
(Hou et al., 2008; Langer et al., 2008) and of nuclear receptors
(Hou et al., 2010). During embryonic development Ajuba is
initially expressed rather broadly, including the SHF; however,
it shows distinct subcellular localization in different tissues
(Figures 2E and S4). Later, at E12.5 in mouse embryos and 48
hpf in zebrafish embryos (Goyal et al., 1999), it acquires a more
specific expression pattern (data not shown). This temporal
and spatial expression pattern suggests that Ajuba may play
a regulatory role during early organogenesis. Inactivation of
Ajuba led to defects in neural crest development in Xenopus
(Langer et al., 2008) and left–right axis determination in medaka,
due to defects in ciliogenesis (Nagai et al., 2010). No develop-
mental defects in single knockouts of the Ajuba protein family
members, Ajuba and LIMD1, were observed in mice, which
suggests a potential compensation and redundant functions
within the Ajuba/Zyxin protein family members during mouse
development (Feng et al., 2007; Marie et al., 2003). More
recently, however, it was reported that the Ajuba family member
WTIP, which is also expressed in the developing heart, plays an
important role during early embryonic development because no
WTIP-deficient embryos were observed as early as E8.5 (Kim
et al., 2012).
We have gathered compelling evidence that Ajuba proteins,
which interact with Isl1, restrict the activity of Isl1, thereby play-
ing an important role in regulating SHF expansion and morpho-
genetic control of cardiogenesis. Notably, Ajuba-deficientDzebrafish embryos displayed an increased pool of Isl1+ cardiac
progenitors and, subsequently, dramatically increased numbers
of atrial and ventricular cardiomyocytes, derived from the SHF.
The higher number of atrial cells was due to dramatically higher
numbers of mGFP+/dsRed Isl1-positive atrial cardiomyocytes
at the venous pole of the heart tube, which are added later to
the heart tube in a process that requires Isl1 activity (Figures
3C and 3D; de Pater et al., 2009). Furthermore, we detected
a significantly enlarged outflow pole, which can be explained
by enhanced contribution of the increased pool of Isl1+ cardiac
progenitors to the arterial pole (Figures 3E and 3F; Hami et al.,
2011). Additionally, the ability of Ajuba to limit cardiomyocyte
numbers at both poles of the heart depends on Isl1 because
the double Isl1/Ajuba-deficient zebrafish embryos did not
show any increase in the total number of cardiomyocytes in
contrast to the Ajuba morphants (Figure 4E; Figure S3E).
Because previous reports have not observed defects in the
arterial pole of Isl1-deficient zebrafish embryos (de Pater et al.,
2009), our results might indicate that Ajuba controls additional
factors besides Isl1, which are involved in the differentiation of
the arterial pole, e.g., Nkx2.5 or other Isl1 homologs that we
detect expressed at the arterial but not at the venous pole of
the heart (unpublished data). Additionally, we observed cardio-
myocytes in the pericardial wall adjacent to the heart in Isl1/
Ajuba morphants (Figure 4E, arrows). One possible explanation
could be that Ajuba and Isl1 are required to direct the migration
of cardiac cells into the heart tube, consistent with the proposed
role of Ajuba and Isl1 in regulating migration (Cai et al., 2003;
Pratt et al., 2005). Interestingly, we observed dramatically
expanded Isl1+ cell population in Ajuba, Isl1, and Isl1/Ajuba mor-
phants. However, in contrast to the control and Ajuba morphant
embryos, where Isl1+ cardiomyocytes are localized at the
venous pole, the dramatically expanded Isl1+ cell population in
both Isl1 and the double Isl1/Ajuba-deficient embryos was found
outside of the heart tube. Taken together, these data suggest
that Ajuba and Isl1 restrict the number of Isl1+ cells, whereas
Isl1 presumably in collaboration with other cofactors drives the
differentiation of cardiomyocytes (Figure 4E–4G and 7H), consis-
tent with previous reports (Kwon et al., 2009).
The significant upregulation of Mef2ca, Mef2cb, Tbx20, Tbx1,
and Bmp4, which play important roles in the formation of the
SHF (Hami et al., 2011; Lazic and Scott, 2011; Vincent and
Buckingham, 2010), after Ajuba depletion and the increased
number of Isl1+ cardiac progenitors in Ajuba morphants sug-
gests an important role for Ajuba in restricting the SHF progenitor
cell pool. Furthermore, our data demonstrated dramatically
increased specification of cardiac progenitors at early stages
of heart development in Ajuba-deficient embryos (Figure 5B).
Moreover, our results suggest that Ajuba directly represses Isl1
expression by binding to the Isl1 enhancer in an Isl1-dependent
mechanism (Figure 6C–6E). Additionally, Ajuba suppresses
Isl1-mediated activation of Mef2c in the SHF because Ajuba
and Isl1 form a complex at the Mef2c AHF enhancer. The nega-
tive regulatory role of Ajuba for Isl1 and the SHF was further sup-
ported by gain-of-function experiments in the mouse system,
where we detected a significantly decreased expression of
Isl1 and other SHF markers in EBs overexpressing Ajuba. We
assume that the function of Ajuba proteins is conserved during
evolution, although the relative contribution of the different familyevelopmental Cell 23, 58–70, July 17, 2012 ª2012 Elsevier Inc. 67
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Ajuba Restricts the Cardiac Progenitor Poolmembers and the level of redundancy between them might
differ. The contribution of Ajuba to cardiovascular development
in the mouse might be masked by the action of WTIP, which is
highly related to Ajuba. Although Ajuba-deficient mice do not
show a cardiovascular phenotype, ablation of WTIP, which is
expressed in the developing heart, is embryonically lethal before
E8.5 (Kim et al., 2012). Furthermore, WTIP depletion in zebrafish
embryos results in an increase of Isl1+ cells at the venous pole,
analogous to the one observed for Ajuba. Alternatively, the lack
of a cardiac phenotype in mouse Ajuba mutants may be due
to differences in the properties of the SHF cardiac progenitors
in zebrafish and mouse because proliferating Isl1+ cardiac
progenitor cells are rare in zebrafish (Figure S6), but abundant
in mouse embryos (Cai et al., 2003), a property essential for the
development of the four-chambered heart in the mouse.
RA signaling regulates key aspects of heart development and
is required to limit the posterior extent of the SHF (Ryckebusch
et al., 2008; Sirbu et al., 2008). In the zebrafish embryo, RA has
been shown to restrict the cardiac progenitor cell pool, and
Raldh2 deficiency causes the formation of enlarged hearts
composed of higher numbers of both atrial and ventricular cells
(Keegan et al., 2005;Waxman et al., 2008). Our data suggest that
Ajuba is an important downstream effector of RA signaling that
regulates the cardiac progenitor pool, based on the following
lines of evidence: (1) RA treatment led to upregulation of Ajuba
and its accumulation in the nucleus (Figure 6B), which resulted
in concomitant binding of Isl1 and Ajuba to the Isl1 enhancer
and downregulation of Isl1 expression (Figures 6C–6E); and (2)
RA-mediated restriction of the number of Isl1+ cells in the zebra-
fish heart depends on Ajuba because treatment of Ajuba
morphants with RA failed to affect the number of Isl1+ cells (Fig-
ure 6G). Taken together, our data suggest that the Isl1-Ajuba
transcriptional complex negatively regulates Isl1 expression
downstream of RA signaling.
It has been shown that a Nkx2.5/Bmp2/Smad1 negative feed-
back loop controls cardiac progenitor cell specification and
proliferation (Prall et al., 2007). Interestingly, Nkx2.5 was down-
regulated in Ajuba morphants. Additionally, exogenously ex-
pressed Nkx2.5 interacted with Ajuba, and overexpression of
Ajuba correlated with increased Nkx2.5 levels. Given the fact
that Nkx2.5 levels are tightly regulated in cardiac progenitors
and increase from progenitor to the differentiated state, it is
tempting to speculate that Ajubamight be an important regulator
of this process that is crucial for the early events of cardiac devel-
opment (Prall et al., 2007). We suggest that downregulation of
Nkx2.5 in Ajuba morphants may contribute to increased specifi-
cation of Isl1+ cardiac progenitors, similar to the studies in
Nkx2.5 knockout mice (Prall et al., 2007). However, further
work will be required to determine the mechanisms through
which Ajuba affects Nkx2.5 levels and how this is linked to the
restriction of the Isl1+ progenitor pool.
We propose a model in which Ajuba restricts the SHF progen-
itor pool by regulation of the activity and stability of two key
transcription factors in heart development, Isl1 and Nkx2.5
(Figure 7H). Ajuba binds Isl1 and represses its transcriptional
activity, which on the one hand is required to downregulate the
expression of key transcription factors in the SHF such as
Mef2c and on the other hand enables Isl1 to suppress its
own expression, a process that is RA dependent. According to68 Developmental Cell 23, 58–70, July 17, 2012 ª2012 Elsevier Inc.this model, stabilization of Nkx2.5 by Ajuba may be involved in
preventing cardiac progenitor cell overspecification.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
HEK293T, NIH 3T3, and p19 cells were grown in DMEM (Invitrogen) supple-
mented with 10% fetal bovine serum (FBS) (Invitrogen), 2 mM L-glutamine,
100 U/ml penicillin, and 100 mg/ml streptomycin (Invitrogen) at 37C, 5%
CO2. Undifferentiated ES cells were maintained on mouse embryonic
fibroblast (MEF) feeder cells in DMEM supplemented with 15% FBS, 2 mM
L-glutamine, 0.1 mM 2-mercaptoethanol (Sigma-Aldrich), 0.1 mM nonessen-
tial amino acids (Invitrogen), 1 mM sodium pyruvate (Invitrogen), 4.5 mg/ml
D-glucose, and 1,000U/ml of leukemia inhibitory factor (LIF ESGRO;Millipore).
To induce EB formation, dissociated ES cells were cultured in hanging drops,
with a density of 500 cells per drop in 15 ml of ES cell medium, in the absence
of LIF. After 2 days in the hanging drop culture, the resulting EBs were trans-
ferred to bacterial culture dishes.
Plasmids and Antibodies
For detailed plasmid information, see the Supplemental Experimental Proce-
dures. The following primary antibodieswere used: rabbit anti-HA (Y-11; Santa
Cruz Biotechnology); rabbit anti-Nkx2.5 (H-114; Santa Cruz Biotechnology);
mouse anti-myc (9E11; Santa Cruz Biotechnology); mouse anti-Islet1 39.4D5
(Developmental Studies Hybridoma Bank); chicken anti-GFP (Millipore); goat
anti-Lamin B (C-20; Santa Cruz Biotechnology); and anti-Ajuba (Cell Signaling;
H-155 [Santa Cruz Biotechnology]).
Immunoprecipitation, Immunoblotting, ChIP, and
Immunofluorescence
Detailed protocols are described in Supplemental Experimental Procedures.
Luciferase Assay
For luciferase assays, 1.5–2 3 104 HEK293T or NIH 3T3 cells were seeded in
24-well plates. Forty-eight hours after transfection, cells were lysed in 100 ml
lysis buffer (Promega; Luciferase Assay System), and luciferase activity was
measured on a Mithras LB 940 reader (Berthold Technologies) according to
the Luciferase Assay System Manual. b-Galactosidase assays were per-
formed using chlorophenolred-b-d-galactopyranoside (CPRG) substrate
(Sigma-Aldrich).
RNA Isolation, RT-PCR, and Real-Time PCR
RNA was isolated using the Total RNA Isolation Reagent (ABgene). cDNA was
synthesized with the High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems), and real-time PCR was performed using the SYBR Green PCR
Master Mix (Applied Biosystems). The cycle numbers were normalized to
GAPDH (ES/EBs) or Rpl13a (zebrafish embryos). Primer pairs are described
in Supplemental Experimental Procedures.
Zebrafish Strains
Animal experimentswere performed in accordancewith the institutional guide-
lines. Embryos and adult zebrafish were raised under standard laboratory
conditions at 28C. The following mutant and transgenic lines were used:
Tg(myl7:EGFP-HsHRAS)s883 and Tg(5.1myl7:nDsRed2)f2 (Mably et al.,
2003; D’Amico et al., 2007). To generate the Nkx2.5:GFP line, the 6 kb
upstream regulatory region of the nkx2.5 gene was amplified using primer
pairs (50-GGGGACAACTTTGTATAGAAAAGTTGCCCAAGCCCACTTACCAA
TA-30 and 50-GGGGACTGCTTTTTTGTACAAACTTGGGATAATCCGGTTGGG
ATTT-30) and combined into pME-GFP together with p3E-polyA and
pDestTol2pA2 to generate nkx2.5:GFP:pA construct, which was injected into
one-cell stage embryos. The generation of the nkx2.5:GFP line is covered
in an approved animal protocol by the University of Southern California
Institutional Animal Care and Use Committee.
Morpholinos
MOs (GeneTools) were prepared at a stock concentration of 1 mM and diluted
to the desired concentration for microinjection. To block translation, embryos
Developmental Cell
Ajuba Restricts the Cardiac Progenitor Poolwere injected with 9 ng of the Ajuba AUG MO: 50-TGAGTTTGATGCCAAGTC
GATCCAT-30. To block splicing, embryos were injected with 9 ng of Ajuba
Sp MO: 50-GATGGGTTTGTGATCTCACCGAAGT-30. Uninjected and control
MO-injected embryos served as controls.
Nkx2.5/Nkx2.7 MO knockdown experiments were performed as described
(Targoff et al., 2008). Isl1 MO knockdown experiments were performed as
described (Hutchinson and Eisen, 2006).
In Situ Hybridization, Whole-Mount Immunostaining,
and Confocal Microscopy
In situ hybridization was performed as described in Thisse et al. (2004). Whole-
mount staining was performed as described (Dong et al., 2007). Confocal
images were acquired by a Zeiss LSM 710 system, and the z stacks were pro-
jected by Zeiss LSM 710 software.
RA and DEAB Treatments
For RA treatment embryos were exposed to 0.1 or 0.3 mMRA, 1%DMSO in E3
medium (fish water) for 1 hr beginning at 50% epiboly. DEAB (4-diethylamino-
benzaldehyde; Sigma-Aldrich) in 1% DMSO, E3 medium was applied at final
concentration of 5 mM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.devcel.2012.06.005.
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